Characteristics of Nemaline Myopathy Clarified by Cross Sectional Study
NM was found to have a stable disease course and the most common classification was typical congenital.
Challenges of Treating Chronic Insomnia: Jennifer Martin, PhD
The AASM board of directors member and professor of medicine at UCLA also discussed the relative inefficacy of sleep hygiene therapy for insomnia.
Cure SMA Launches Physical Therapy Webinars
The webinars, for adults and children with SMA, were produced in conjunction with Biogen and the Luke 18:1 Foundation.
Cladribine for Treatment of RMS
Atrophy Subtypes May Predict Cognitive Decline Patterns, Rates of Conversion to Dementia
Hippocampal-sparing and limbic-predominant atrophy were also associated with incident dementia, with faster cognitive decline in the limbic predominant atrophy group.
NeuroVoices: Christian Agudelo, MD, on Sleep’s Impact on Cognitive Decline
The Evelyn F. McKnight Neurocognitive Scholar at the University of Miami Miller School of Medicine detailed his study on the correlations between sleep and cognitive decline in middle-aged Hispanics.
ADDF Calls for Global Partnership to Compile Speech Biomarkers in Early Alzheimer
New technology enables the collection and analysis of speech behaviors, but this requires an extensive database, which the ADDF seeks to help develop.
ELEKTRA Study in Dravet and Lennox-Gastaut Syndromes
Inaccuracies With Valproic Acid Free Concentration Identified in Status Epilepticus
The calculation of fVPA based on this equation resulted in a misinterpretation in 40% of measurements with around 75% of them overestimating the actual measured fVPA.
Pavel Klein, MD: Determining Likelihood of Efficacy and AEs in Patient Populations
The director of the Mid-Atlantic Epilepsy and Sleep Center discussed his team’s investigations into predicting responders and adverse events.
Praxis Medicines Wins Rare Disease and Orphan Drug Designations for DEEs
Including these agents for developmental and epileptic encephalopathies, the relatively young company has 5 programs under development to target rare neurological disorders.
TS Alliance E-Webinar Series
A look into the numerous education series upcoming in 2021 by the Tuberous Sclerosis Alliance
CYCLE-AD Trial: High-Intensity Exercise to Stave Off Alzheimer Disease
New NIH-funded study tests home-based intervention in high-risk group.
FDA Clears First Rapid Traumatic Brain Injury Blood Test
Having a blood test available could help eliminate wait time in the emergency room and could reduce the number of unnecessary CT scans by up to 40%, according to Abbott, the test’s developer.
Dietary Vitamin C and E Associated with Lower Risk of Parkinson Disease
Further associations with lowered risk of Parkinson were observed with BMI and coffee intake.
Richard B. Lipton, MD: Achieving Simultaneous Acute and Preventive Migraine Treatment
The director of the Montefiore Headache Center discussed how his team’s findings can change the way physicians think about treating migraine.
Causal Link Between Smoking and Subarachnoid Hemorrhage
People who were genetically predisposed to smoking behaviors were at a 63% greater risk for subarachnoid hemorrhage.
Anti-CD20 Monoclonal Antibodies for Treatment of RMS
Inconsistencies Identified Across EEG Neurology Education Tactics
The findings showed that 64% of EEG education programs did not utilize objective measures to assess EEG milestones.
The Role of Developing Agents in Acute Migraine Paradigm
CGRP Receptor Agonists: Safety and Efficacy
5-HT1F Agonist Toxicity Profile and Role in Paradigm
The Significance of 5-HT1F Agonist Approval
Recent Approvals for Acute Migraine
The Importance of Patient Communication
Therapy Assessment: Pain Relief & Onset Monitorization
Acute Migraine Treatment: Pain Freedom and Guidelines
Goals of and Recommended Approach for Acute Treatment
Acute Migraine Management: Overview and Unmet Needs
This Week on NeurologyLive — January 18, 2021
Here's what is coming soon to NeurologyLive.
